Thursday May 25th 2017

Posts Tagged ‘zamboni’

Knutsford man to travel to Poland for pioneering MS surgery

Knutsford man to travel to Poland for pioneering MS surgery

A MAN who suffers from a paralysing disease is set to travel to Poland for a pioneering treatment which could reverse his condition. Colm McLaughlin, who has multiple sclerosis (MS), will fly to a clinic in Krakow on June 22 for a radical treatment which has divided the [Read More]

Controversial treatment creating bitterness in MS Society elections

Controversial treatment creating bitterness in MS Society elections

The Multiple Sclerosis Society’s national board election next week is expected to become a battleground as members rally to shut out supporters of a controversial treatment. An e-mail circulated on Friday urged MS Society supporters to sign up to become members, which [Read More]

MS patients tell MPs about life after ‘liberation’

MS patients tell MPs about life after ‘liberation’

A group of patients with multiple sclerosis gathered on Parliament Hill Tuesday to testify how a controversial new treatment has changed their lives, as two Liberal MPs reiterated their call for more research. The patients included Steve Garvie and Lianne Webb, both of whom [Read More]

 Page 1 of 5  1  2  3  4  5 »

Latest Topics

MS Study Alert: Share Your Thoughts About MS Research

MS Study Alert: Share Your Thoughts About MS Research

/About-the-Society/News/MS-Study-Alert-Share-Your-Thoughts-About-MS-Resea [Read More]

Mallinckrodt begins enrolment in Phase IV trial of HP Acthar gel for RRMS

Mallinckrodt begins enrolment in Phase IV trial of HP Acthar gel for RRMS

UK-based specialist pharmaceutical firm Mallinckrodt has begun patient enrolment in the Phase IV OPTIONS clinical trial [Read More]

First Results Announced from Second Phase III Trial of Oral Ozanimod in People with Relapsing MS

First Results Announced from Second Phase III Trial of Oral Ozanimod in People with Relapsing MS

/About-the-Society/News/First-Results-Announced-from-Second-Phase-III-Tria [Read More]

Experimental treatment tempers HLH, MS symptoms in mouse models, study shows

Experimental treatment tempers HLH, MS symptoms in mouse models, study shows

Immune diseases like multiple sclerosis and hemophagocytic lymphohistiocytosis unleash destructive waves of [Read More]

Celgene ’s Phase III trial of ozanimod for RMS meets primary endpoint

Celgene ’s Phase III trial of ozanimod for RMS meets primary endpoint

US-based biopharmaceutical firm Celgene has reported positive results from the Phase III RADIANCE clinical trial of [Read More]